Multicenter, Phase 2, Randomized Controlled Study of the Efficacy and Safety of Etripamil Nasal Spray for the Acute Reduction of Rapid Ventricular Rate in Patients With Symptomatic Atrial Fibrillation (ReVeRA-201)
一项多中心、II期、随机对照研究,旨在评估依曲帕米鼻喷雾剂急性降低有症状房颤患者快速心室率的疗效和安全性(ReVeRA-201)
期刊:Circulation-Arrhythmia and Electrophysiology
影响因子:9.8
doi:10.1161/CIRCEP.123.012567
Camm, A John; Piccini, Jonathan P; Alings, Marco; Dorian, Paul; Gosselin, Gilbert; Guertin, Marie-Claude; Ip, James E; Kowey, Peter R; Mondésert, Blandine; Prins, Fransisco J; Roux, Jean-Francois; Stambler, Bruce S; van Eck, Jwm; Al Windy, Nadea; Thermil, Nathalie; Shardonofsky, Silvia; Bharucha, David B; Roy, Denis